主要胃肠道中毒性卡波西肉瘤:一个罕见的儿科病例报告
Nil Urganci1, Ayse Mine Onenerk Men1, Nuray Kepil1
1Department of Pathology, Istanbul University Cerrahpasa-Cerrahpasa Faculty of Medicine, Istanbul, Turkey.
概括
异位性卡波西肉瘤 (KS) 是一种罕见的血管瘤,在免疫抑制疗法后诊断出患有慢性颗粒性疾病 (CGD) 的儿科患者. 这一案例凸显了在免疫受损儿童中识别这种恶性瘤的重要性.
科学领域:
- 在瘤学瘤学.
- 儿科 儿科 儿科
- 免疫学 免疫学 免疫学
背景情况:
- 卡波西肉瘤 (KS) 是一种罕见的人类疹病毒-8 (HHV-8) 相关的血管瘤.
- 它通常影响皮肤,但可以涉及内脏器官,特别是在免疫抑制个体.
- 在成年人中记录了Iatrogenic KS,但在儿科病例中没有报告孤立的胃肠道干扰.
研究的目的:
- 报告一个儿科患者罕见的阴性卡波西肉瘤病例.
- 强调需要提高对免疫受损儿童这种恶性瘤的认识.
- 突出免疫抑制疗法与罕见并发症风险之间的平衡.
主要方法:
- 一个16岁的男性患有慢性粒状细胞疾病 (CGD) 的病例报告.
- 患者出现了类似炎症性肠病的症状,并接受了免疫抑制疗法.
- 临床过程涉及复发性感染,肝炎,肠道穿孔和切除术.
主要成果:
- 组织病理学证实阴性卡波西肉瘤 (KS) 是肠道穿孔的原因.
- 患者的症状和并发症与长期的CGD免疫抑制治疗有关.
- 这代表了儿科患者中罕见的隔离性胃肠道KS病例.
结论:
- 在免疫功能低下的儿科患者中,应考虑Iatrogenic KS,这些患者呈现出无法解释的胃肠道症状.
- 仔细考虑长期免疫抑制疗法的风险和益处对于管理像CGD这样的疾病至关重要.
- 这一案例强调了对儿科患者罕见机会性恶性瘤的警监测的重要性.
相关概念视频
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
975
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
975
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
414
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
414
01:28Kidney Transplant I: Introduction
849
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
849